Home > Healthcare > Drug Device Combination > Therapeutic Systems > Cervical Dysplasia Market

Cervical Dysplasia Market Share

Report ID: GMI9898
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Cervical Dysplasia Market Share

The market is characterized by the presence of several key players striving to develop innovative diagnostic and treatment solutions. Major companies are leading the market with their comprehensive portfolios of cervical cancer screening tests and diagnostic tools. Also, pharmaceutical companies play a significant role in developing vaccines against high-risk HPV strains, which are essential for preventing cervical dysplasia. Strategic collaborations, mergers, and acquisitions are common strategies among market players to strengthen their market presence and expand their product offerings.

Cervical Dysplasia Market Companies

Few of the prominent players operating in the cervical dysplasia industry include:

Abbott Laboratories
Asieris Pharmaceuticals
Becton, Dickinson and Company,
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hologic Inc.
Kinopharma
Merck & Co., Inc.
OncoHealth Corporation
Qiagen

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Cervical dysplasia market size was USD 675.5 million in 2023 and is expected to register 7.1% CAGR from 2024-2032 owing to the increasing prevalence of human papillomavirus (HPV) infections, which are closely linked to the development of cervical dysplasia worldwide.

Cervical dysplasia industry from the low-grade cervical dysplasia segment is expected to register 7.2% CAGR from 2024-2032 due to its higher prevalence compared to high-grade dysplasia.

The U.S. cervical dysplasia industry reached USD 272.1 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to advanced healthcare infrastructure, high prevalence of HPV infections, and widespread cervical cancer screening programs in the region.

Abbott Laboratories, Asieris Pharmaceuticals, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hologic Inc., Kinopharma, Merck & Co., Inc., OncoHealth Corporation, and Qiagen, are some of the major cervical dysplasia companies worldwide.